Study of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple Myeloma
Clinical trial NCT03672318 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03672318
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-14
- Primary completion
- 2024-10-16
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.